TherapeuticsMD | TXMD - Pre Tax Profit

Stock Price
2.29
Daily Change
0 0%
Monthly
1.33%
Yearly
126.73%
Q1 Forecast
2.17

TherapeuticsMD reported $-1.05M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Novo Nordisk DKK 25.52B 8.29B Sep/2025
Pfizer USD 3.33B 290M Sep/2025
TherapeuticsMD USD -1.05M 241K Jun/2024